Both senators had an aggressive form of brain cancer called glioblastomas.
In addition to his lifetime of public service, McCain moved the needle on glioblastoma awareness.
The senator has already "surpassed expectations for his survival."
Zika's most damaging quality could be weaponized against brain tumor cells.
The widely revered senator's record is less "maverick," and more "party loyalist."
But unlike you, she didn’t have insurance, so she could not follow through with the treatment.
My heart goes out to the McCain family and to all families who have to deal with this horrible reality.
End of life decisions and definitions of dignity vary widely. For Don, cognition and continence were paramount. In the end, he had neither. Yet by my definition of dignity, he prevailed.
The early bird gets the worm. Slow and steady wins the race. For those of us who are parents, these may be familiar sayings that we tell our children to either get them moving, or instead have them slow down.
For those of us who were spared by fate and vaccine, Philip Roth's Nemesis charts polio's course and brings to mind the friends and neighbors who suffered the withering and the life-long incarceration of limbs.
To hear the words "cancer" and "cure" in the same sentence from experienced cancer researchers is both breathtaking and unexpected. Researchers and top oncologists are usually cautious to a fault.
Remember with me the second Phil Schneiderman, who told us each day -- and in each blink of his closing eye -- that he knew, when it mattered most, what it meant to love us each in return.
— Median age of the deceased: 71 — Percentage who had at least some college: 72 — Percentage of patients who informed relatives
I know that the meaning my father's slow death -- and yes, his continuing if uncomfortable life -- may well be no meaning at all. So, please, Internet troll, don't bury a man who (if he gets his way) will still be here 10 years from now.
"It's an aggressive form of cancer so it needs to be treated aggressively," Frankland told the New Hampshire Union Leader
It's time for governments, cancer organizations, and the cancer industry to devote their resources primarily to immunotherapy and give it urgent priority.